Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CCR registry of antiplatelet therapy in acute coronary syndrome patients undergoing PCI
NL-OMON20101Recruiting
- Sponsor
- Eli Lilly
- Start
- Sep 2011
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label trial of prasugrel, clopidogrel and aspirin in acute coronary syndrome (ACS) (2 cohorts), sponsored by Eli Lilly. Primary endpoint: Composite of all-cause mortality and nonfatal myocardial infarction. Started Sep 2011; status: recruiting.
02
Drugs
prasugrelclopidogrelaspirin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NL-OMON20101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON20101.